NCT05472974

Brief Summary

The aim of the study is to determine the clinical value of using a powered alternating pressure air mattress (P-APAM) in the prevention of pressure injury (PI) in patients at medium to high risk. This study is noncomparative, observational study. Patients older than 18 years of age, with a medium to high risk of PI, without PI, up during the day, and lying more than 15 hours a day on a specific P-APAM were included. The study was conducted in nursing homes, and in long-stay geriatrics department. Patients are followed up for 35 days. The use of the P-APAM is associated with the usual PI prevention measures. The primary outcome is the percentage of patients who developed between day 0 and day 35 at least one PI of at least stage 2 on the sacrum, spine, or heel. Secondary endpoints are patient assessments of comfort, caregiver satisfaction, mattress noise level, and mattress safety.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
86

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Sep 2018

Shorter than P25 for all trials

Geographic Reach
1 country

5 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 17, 2018

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 22, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 22, 2019

Completed
3 years until next milestone

First Submitted

Initial submission to the registry

July 21, 2022

Completed
4 days until next milestone

First Posted

Study publicly available on registry

July 25, 2022

Completed
Last Updated

July 26, 2022

Status Verified

July 1, 2022

Enrollment Period

10 months

First QC Date

July 21, 2022

Last Update Submit

July 23, 2022

Conditions

Keywords

Pressure injuryLife support systemBedsPrevention

Outcome Measures

Primary Outcomes (1)

  • percentage of patients who developed at least one stage 2 pressure injury

    Percentage of patients who developed at least one stage 2 PI of the sacrum, backbone, or heel (areas of support when lying down)

    35 days after installation on the mattress (at day 35)

Secondary Outcomes (5)

  • Percentage of patients who developed a o pressure injury (any stage), other than those of the sacrum, backbone, or heel between

    35 days after installation on the mattress (at day 35)

  • Assessment by the patient (or family or staff in the case of incapacity) of the comfort of the mattress (general comfort, stability)

    35 days after installation on the mattress (at day 35)

  • Assessment by the nursing staff with the use of the mattress (implementation, cleaning maintenance turning, changing to a sitting position)

    35 days after installation on the mattress (at day 35)

  • Assessment of the degree of maceration

    35 days after installation on the mattress (at day 35)

  • Assessment of mattress safety

    At day 35

Interventions

Patients with a medium to high risk of pressure injury, without pressure injury, up during the day, will ly a on a specific P-APAM (DOMUS 4 /AUTO)

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients in nursing homes or long-stay geriatrics department

You may qualify if:

  • Patient over 18 years old
  • Patient with a medium to high risk of developing pressure ulcers (clinical judgment and a score of \[10 to 14\] on the Braden scale (6 (maximum risk) to 23 (no risk))
  • Patient up during the day, lying between 3 p.m. and 8 p.m. a day on a Domus 4 / AUTO mattress
  • Patient with a weight \< 200 kg
  • Patient (or a trusted third party) having been informed of the study and agreeing to participate

You may not qualify if:

  • Patient at end of life (estimated life expectancy less than 6 months)
  • Malnourished patient according to the french health authority (Haute Autorité de la santé) definition\*
  • \* For adults under 70:
  • weight loss ≥ 5% in one month or ≥ 10% in six months
  • or body mass index (BMI) ≤ 18.5 (excluding constitutional thinness)
  • for adults over 70:
  • weight loss ≥ 5% in one month or ≥ 10% in six months
  • or BMI ≤ 21
  • or Mini Nutritional Assessment (MNA) ≤ 17 (/30)
  • or albuminemia \< 35 g/L

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (5)

Ehpad Du Parc Chateau D'Abondant

Abondant, France

Location

Ehpad Esbv

Baugé-en-Anjou, France

Location

Ehpad Residence Le Parc

Fontenay-aux-Roses, France

Location

Ehpad Duc de Lorge

Saint-Jean-d'Illac, France

Location

Ehpad Villa Du Tertre

Saint-Parres-aux-Tertres, France

Location

MeSH Terms

Conditions

Pressure Ulcer

Condition Hierarchy (Ancestors)

Skin UlcerSkin DiseasesSkin and Connective Tissue Diseases

Study Officials

  • Sylvie MEAUME, Pr

    Hôpital ROTSCHILD

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 21, 2022

First Posted

July 25, 2022

Study Start

September 17, 2018

Primary Completion

July 22, 2019

Study Completion

July 22, 2019

Last Updated

July 26, 2022

Record last verified: 2022-07

Data Sharing

IPD Sharing
Will not share

Locations